Resource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed)
Issued by National Institutes of Health · via Grants.gov — US federal funding opportunities
- Published
- 5 Dec 2025
- Closes
- 28 Sept 2028, 23:59 UTC
- Value
- USD 5,000,000
- Reference
- RFA-OD-25-010
- Location
- United States
- Sector
- Healthcare & Pharma
Details
The Office of Research Infrastructure Programs (ORIP) encourages grant applications aimed at developing, characterizing, or improving research models of human health and diseases; developing biology based new approach methodologies (NAMs) applicable to human health and diseases; or improving access to information about or generated from the use of models of human disease. The models, including NAMs, and related biological materials developed must be broadly applicable to the scientific interests of two or more NIH Institutes or Centers (ICs) and must evaluate diseases and processes that impact multiple organ systems in order to align with the ORIP"s NIH-wide mission and programs. Applications must describe the need for and the potential impact of the proposed resources on the research community across a range of scientific disciplines supported by multiple NIH ICs. Applications to develop models that relate strictly to a specific disease or a select area of research or that do not have a broad impact on the NIH-wide research community will not be accepted. Projects that predominantly address the research interests of one NIH IC but are only peripherally related to the research interests of other ICs will also not be accepted, if submitted in response to this notice of funding opportunity (NOFO). Eligibility: Refer to Section III. Eligibility Information of the NOFO for additional information on eligibility.Foreign Organizations/Foreign CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Estimated total programme funding: USD 5000000
Expected number of awards: 6
CFDA number(s): 93.351
Federal funding opportunity published on Grants.gov. Applications are submitted through Grants.gov — see the official listing.
Context for bidders
We hold 411 notices from National Institutes of Health, going back to May 2023 — 378 of them still open. They buy mostly in Healthcare & Pharma, Education & Training and Water & Environment. There are 369 open Healthcare & Pharma tenders in United States. This one closes in 731 days.
More from this buyer
- Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)· closes 5 Nov
- NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)· closes 16 Nov
- Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)· closes 25 May
- Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)· closes 10 Nov
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)· closes 10 Nov
Similar Healthcare & Pharma tenders
- Bag, Medical Instrument — 25 each, NSN 6545016918890· closes 5 Oct
- Scanner, Acquisition, TH — 1 each, NSN 6520017024522· closes 5 Oct
- Ventilator, Volume, Port — 6 each, NSN 6515017029684· closes 5 Oct
- Comprehensive Medical Services -FDC Houston — General Health Care Services· closes 17 Nov
- 2027 Southern Hemisphere Influenza Vaccine — Drugs and Biologicals· closes 14 Oct
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
More Healthcare & Pharma tenders
- Maintenance services for GE color digital imaging systemsوزارة الصحة · Jordan
- Maintenance and provision of resident technical personnel for the elevators at Dr. Jamil Al-Tutunji Hospital / Sahabوزارة الصحة · Jordan
- Procurement method: المناقصة المحدودة (الأستدراج)وزارة الصحة · Jordan
- Atomoxetine Caps 25 MGوزارة الصحة · Jordan
- Procurement of Dental Supplies Ref # RFQ-SFO-NFI-26-081UNRWA · Syria
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →